Methotrexate-induced liver toxicity: Replacing the liver biopsy

JAMA Dermatology

Volumn 150, Issue 8, 2014, Pages 862-863

  Strober, Bruce E ^a,b  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b PROBITY MEDICAL RESEARCH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 MACROGLOBULIN; APOLIPOPROTEIN A1; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE; HAPTOGLOBIN; LIVER ENZYME; METHOTREXATE; PROCOLLAGEN TYPE 3; UNCLASSIFIED DRUG; IMMUNOSUPPRESSIVE AGENT;

AGE DISTRIBUTION; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; DRUG INDUCED DISEASE; ELASTOGRAPHY; HISTOPATHOLOGY; HUMAN; LIVER BIOPSY; LIVER FIBROSIS; LIVER FUNCTION TEST KIT; LIVER PARENCHYMA; LIVER TOXICITY; LONG TERM CARE; MORBIDITY; NONALCOHOLIC FATTY LIVER; NOTE; PAIN; PATIENT MONITORING; PRIORITY JOURNAL; PSORIASIS; PSORIATIC ARTHRITIS; DRUG EFFECT; DRUG MONITORING; ECHOGRAPHY; FEMALE; LIVER; MALE; METHODOLOGY; TOXIC HEPATITIS;

DRUG MONITORING; DRUG-INDUCED LIVER INJURY; ELASTICITY IMAGING TECHNIQUES; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER; MALE; METHOTREXATE;

EID: 84906748945     PISSN: 21686068     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamadermatol.2014.681     Document Type: Note

References (3)

1. van der Voort EA, Koehler EM, Dowlatshahi EA, et al. Psoriasis is independently associated with nonalcoholic fatty liver disease in patients 55 years old or older: results from a population-based study. J AmAcad Dermatol. 2014;70(3):517-524.
2. Lynch M, Higgins E, McCormick PA, et al. The use of transient elastography and FibroTest for monitoring hepatotoxicity in patients receiving methotrexate for psoriasis [published online June 25, 2014]. JAMA Dermatol. doi:10.1001/jamadermatol.2013.9336.
3. Maybury CM, Samarasekera E, Douiri A, Barker JN, Smith CH. Diagnostic accuracy of non-invasive markers of liver fibrosis in patients with psoriasis taking methotrexate: a systematic review and meta-analysis [published online March 4, 2014]. Br J Dermatol. doi:10.1111/bjd.12905.